
    
      Subjects who are candidates for posterior lumbar or lumbosacral spinal fusion without
      anterior interbody support will be screened for inclusion in the study. Participants will be
      enrolled and randomized to either the BMAC + allograft or ICBG group. An enrollment ratio of
      two BMAC + allograft to one ICBG subject (2:1) for up to a total of 40 subjects will be
      enrolled in the study which also accounts for failed screening subjects. The study will
      determine and compare differences in fusion rate and health related quality of life
      parameters at 6 weeks, 3 months, 6 months, 1 year, and 2 years postoperatively.
    
  